| Melva June Broderick, RN | |
|
6881 W State St, #8, Boise, ID 83714-7428 | |
| (208) 850-2653 | |
| Not Available |
| Full Name | Melva June Broderick |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 6881 W State St, Boise, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427399690 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | N-33864 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Melva June Broderick, RN 6881 W State St, #8, Boise, ID 83714-7428 Ph: (208) 850-2653 | Melva June Broderick, RN 6881 W State St, #8, Boise, ID 83714-7428 Ph: (208) 850-2653 |
News Archive
What started off as basic research 25 years ago has now lead to a successfully approved drug: The entry blocker bulevirtide (brand name Hepcludex, formerly known as Myrcludex B), jointly developed by researchers from Heidelberg University Hospital (UKHD) and the Medical Faculty of Heidelberg, the DZIF and other partners, has now been approved by the European Commission.
Cyanotech Corporation, a world leader in microalgae-based, high-value nutrition and health products, today announced its Hawaiian Spirulina Pacifica® has achieved another nutritional first. Already the most nutritious Spirulina in the world, it is also a good source of Vitamin K2.
Teva Pharmaceutical Industries Ltd announced today that it has concluded an Asset Transfer Agreement with NeuroSearch A/S of Denmark to purchase all rights, assets and obligations relating to Huntexil (pridopidine / ACR16), a drug candidate being developed for the symptomatic treatment of hand movement, balance and gait disturbances in Huntington disease (HD).
A team of anthropology researchers has found significant differences in facial features between all seven pre-Columbian peoples they evaluated from what is now Peru - disproving a longstanding perception that these groups were physically homogenous. The finding may lead scholars to revisit any hypotheses about human migration patterns that rested on the idea that there was little skeletal variation in pre-Columbian South America.
The drug was rejected in a 10-6 vote the first time it came before a Food and Drug Administration (FDA) advisory panel, in 2010, due to safety concerns. However when the medication returned for another review in February, the advisory committee gave it near-unanimous approval (20-2). Because the FDA often follows the advisory panel's advice, Qnexa is likely to get FDA approval, probably by mid-April.
› Verified 2 days ago
Robert Fisher, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort St, Boise, ID 83702 Phone: 208-422-1092 | |
Christopher M Gutierrez, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort St, Boise, ID 83702 Phone: 208-422-1000 | |
Trina S Hunter, RN, IBCLC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 8601 W Emerald St Ste 160, Boise, ID 83704 Phone: 208-991-4488 | |
Rebecca Cotterell, RN-BC, BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort St, Boise, ID 83702 Phone: 208-422-1000 Fax: 208-422-1591 | |
Laura Rossow, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort St, Boise, ID 83702 Phone: 208-422-1000 | |
Alicia Curmi, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 417 S 6th St, Boise, ID 83702 Phone: 734-812-3214 | |
Kevin L Coleman, CRNA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 811 N Liberty St, Boise, ID 83704 Phone: 208-323-4522 |